Advancing ADCs through every stage of drug development
Your ADC journey begins with a vision—one in which your drug candidate makes a profound impact on the lives of oncology patients. However, the path to developing these treatments is often characterized by challenges that hinder progress and delay breakthroughs.
ADCs require unique considerations for a variety of assessments, including toxicokinetics, including toxicokinetics, pharmacokinetics, efficacy, patient stratification and more. At Labcorp, we understand the complexities involved in developing ADCs given their highly nuanced chemistry. Our extensive experience delivering answers for ADC developers makes us the ideal lab partner to help you bring these treatments to market, no matter where you are in the development pipeline.